Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Plasma Administration”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03122119
What this trial is testing

Effectiveness of Ultrasound Guided Platelet Rich Plasma Injections in the Sacroiliac Joint

Who this might be right for
Chronic Low Back PainSacroiliitisSacroiliac; Backache+5 more
Star Spine and Sport 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390865
What this trial is testing

Testing MLN0128 (TAK-228) as Potentially Targeted Treatment in Cancers With TSC1 or TSC2 Genetic Changes (MATCH - Subprotocol M)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmRefractory Lymphoma+2 more
National Cancer Institute (NCI) 49
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Not applicableStudy completedNCT04151615
What this trial is testing

VMP Regimen - Safety, Efficacy, and Optimal Dose Finding Study for Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Boryung Pharmaceutical Co., Ltd 203
Testing effectiveness (Phase 2)Study completedNCT00051116
What this trial is testing

A Phase II Study of Continuous Versus Syncopated Dosing of CC-5013 for the Treatment of Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene Corporation 100
Not applicableStudy completedNCT03389347
What this trial is testing

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

Who this might be right for
Plasma Cell LeukemiaRecurrent Multiple MyelomaRefractory Multiple Myeloma
University of Washington 40
Early research (Phase 1)Study completedNCT00599404
What this trial is testing

PK Study to Evaluate Esomeprazole Plasma Levels Following Administration of PN 400

Who this might be right for
Healthy
POZEN 18
Early research (Phase 1)Study completedNCT02159326
What this trial is testing

Microgynon Riociguat Drug Interaction Study in Healthy Postmenopausal Women

Who this might be right for
Drug Interactions
Bayer 31
Not applicableStudy completedNCT02331914
What this trial is testing

GIST: Assessment of Tumor Mutations and TKI Plasma Exposure

Who this might be right for
Gastro-intestinal Stromal Tumor
University Medical Center Groningen 740
Testing effectiveness (Phase 2)Study completedNCT01816971
What this trial is testing

Carfilzomib, Lenalidomide, and Dexamethasone Before and After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Stage I Multiple MyelomaStage II Multiple MyelomaStage III Multiple Myeloma
University of Chicago 76
Large-scale testing (Phase 3)Ended earlyNCT02145598
What this trial is testing

Treatment Optimization in Patients With Untreated Multiple Myeloma

Who this might be right for
Multiple Myeloma
Dr. med. Lars-Olof Muegge 85
Large-scale testing (Phase 3)Ended earlyNCT04502472
What this trial is testing

Treatment of Severe Coronavirus Disease 2019 (COVID-19) With Convalescent Plasma

Who this might be right for
Covid-19
Inova Health Care Services 109
Early research (Phase 1)Study completedNCT01290965
What this trial is testing

Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Who this might be right for
Chronic Hepatitis C
Scynexis, Inc. 57
Not applicableUnknownNCT01615302
What this trial is testing

Is the Use of Blood Platelets Effective in the Treatment of Difficult Fistulas Related to the Anal Sphincter?

Who this might be right for
Rectal Fistula
Maastricht University Medical Center 120
Early research (Phase 1)Active Not RecruitingNCT04754945
What this trial is testing

Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis

Who this might be right for
AL Amyloidosis
Emory University 11
Very early researchUnknownNCT03661554
What this trial is testing

BCMA Nano Antibody CAR-T Cells for Patients With Refractory and Relapsed Multiple Myeloma

Who this might be right for
Relapsed and Refractory Multiple Myeloma
The Pregene (ShenZhen) Biotechnology Company, Ltd. 15
Testing effectiveness (Phase 2)Study completedNCT04750837
What this trial is testing

Platelet Rich Plasma and Diabetic Foot Ulcer

Who this might be right for
Platelet Rich Plasma
Zagazig University 72
Large-scale testing (Phase 3)UnknownNCT05006469
What this trial is testing

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Who this might be right for
BendamustineMultiple Myeloma
Liao Aijun 10
Testing effectiveness (Phase 2)Looking for participantsNCT04776395
What this trial is testing

Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
Emory University 68
Very early researchUnknownNCT06067581
What this trial is testing

The Safety and Efficacy of SENL103 Autologous T Cell Injection

Who this might be right for
Multiple Myeloma
Hebei Senlang Biotechnology Inc., Ltd. 20
Next Page